Spravato, an FDA-approved esketamine nasal spray, offers new hope for treatment-resistant depression, with Aspire TMS Clinic providing personalized, comprehensive care
November 13, 2025
No Comments
Blog & News
- Home
- healthcare-news
Spravato, an esketamine nasal spray, offers rapid relief for treatment-resistant depression. Administered under clinical supervision at Aspire TMS Clinic, it
October 23, 2025
No Comments
